Ethos Financial Group »

Citius Pharmaceuticals shares owned by Ethos Financial Group

Quarter-by-quarter ownership of Citius Pharmaceuticals (CTXR) shares owned by Ethos Financial Group from 13F filings

Historical chart of Ethos Financial Group investment in Citius Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Citius Pharmaceuticals held by Ethos Financial Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Citius Pharmaceuticals by Ethos Financial Group

Quarter filed Position value Share count Share price at filing
2024-03-31 $9.0k 10k 0.90

More positions owned by Ethos Financial Group

Schwab US Broad Market ETF Etf (SCHB)
Vanguard Total World Stock ETF Etf (VT)
Schwab US Large Cap ETF Etf (SCHX)
Vaneck Morningstar Wide Moat ETF Etf (MOAT)
Schwab US Large Cap Growth ETF Etf (SCHG)
Abrdn Physical Gold Shares ETF Etf (SGOL)
iShares Bitcoin TR Etf
iShares TIPS Bond ETF Etf (TIP)
Schwab US Large Cap Value ETF Etf (SCHV)
iShares 0-5 Year TIPS Bond ETF Etf (STIP)
Wisdomtree Managed Futures Strat ETF Etf (WTMF)
Schwab Fundamental Inl Large Com ETF Etf (FNDF)
iShares Short Treasury Bond ETF Etf (SHV)
Energy Select Sector SPDR ETF Etf (XLE)
Apple (AAPL)

View all positions for Ethos Financial Group

Top funds holding Citius Pharmaceuticals

BlackRock
Vanguard Group
Geode Capital Management
Northern Trust
Advisor Group Holdings
Nuveen Asset Management
Charles Schwab Investment Management
Bank of New York Mellon
HighTower Advisors
Morgan Stanley
Inspire Advisors
Rhumbline Advisers
Wealth Advisory Solutions
UBS Group
Arkadios Wealth Advisors

View all funds holding Citius Pharmaceuticals